Alcon reaffirms $10.3B–$10.4B 2025 sales outlook as Unity VCS and new launches drive Q4 acceleration

Q3 2025 Management View CEO David Endicott pointed to building momentum in the second half of 2025, with particular strength in equipment and ocular health. Endicott highlighted, "the launch [of Unity ...
Ophthalmology Times

STAAR Surgical announces amendments to Alcon merger agreement, further delays deal

The timeline for the proposed Alcon acquisition of STAAR Surgical has once again been extended as STAAR announced amendments ...
Hosted on MSN

Staar Surgical Amends Merger Agreement with Alcon

The latest announcement is out from Staar Surgical ( (STAA)). On November 7, 2025, STAAR Surgical Company announced an amendment to its merger agreement with Alcon Inc., introducing a 30-day go-shop ...
Yahoo Finance

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon

LAKE FOREST, Calif., October 27, 2025--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) announced that, in light of ongoing discussions ...
Ophthalmology Times

SpyGlass Pharma releases positive data from 2 trials of Bimatoprost Drug Pad-IOL System

SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...